Cargando…
Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment
This study is to assess the clinical value of in vitro primary cell high-efficiency expansion and high-throughput drug sensitivity screening (HEHDS) system in leukemia, and we evaluated a cohort of 121 patients with acute myeloid leukemia (AML) and 27 patients with acute lymphoblastic leukemia (ALL)...
Autores principales: | Li, Lili, Wang, Wenliang, Liang, Li, Ge, Jian, Xia, Ruixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277151/ https://www.ncbi.nlm.nih.gov/pubmed/35845130 http://dx.doi.org/10.1155/2022/4052591 |
Ejemplares similares
-
Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia
por: Lv, Wenxiu, et al.
Publicado: (2023) -
An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs
por: Mao, Lili, et al.
Publicado: (2013) -
The impact of microfluidics in high-throughput drug-screening applications
por: De Stefano, Paola, et al.
Publicado: (2022) -
High-throughput screening of nanoparticles in drug delivery
por: Tomé, Inês, et al.
Publicado: (2021) -
Application of In Vitro Metabolism Activation in High-Throughput Screening
por: Ooka, Masato, et al.
Publicado: (2020)